OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025

Lung Cancer: Symptoms, Causes, Diagnosis, Treatment, and Prevention

Lung cancer is a form of cancer — an out-of-control growth of abnormal cells — that typically starts in the cells lining the bronchi (tubes that move air into and out of the lungs) or other parts of the lungs, according to the American Cancer Society. ( 1 ) Lung cancer is by far the leading reason men and women die from cancer in the United States, according to the National Cancer Institute, which estimates that the disease accounts for around 2…

OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025

At the 2025 Oncology Pharmacists Connect (OPC) meeting, Kevin Chen, PharmD, MS, BCOP, CPP, reviewed several key studies from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting significant advancements in the treatment of small cell and non–small cell lung cancer.

Advancements Reshape Treatment for Non-Small Cell Lung Cancer

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the RESILIENT-1 and NeoADAURA trials.